Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.1K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

421
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
421
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.7K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.7K
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

8.5K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
8.5K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

101
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
101
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

101
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
101

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Insufflatable Modular Abdominal Simulation Environment (MASE) for Surgical Training Simulation.

Surgical innovation·2026
Same author

Deep learning framework for predicting EGFR mutation status from H&E whole slide images in lung adenocarcinoma.

BMC cancer·2026
Same author

Single-nucleus RNA sequencing dataset of diverse tissues from wild-type monkey and Tau-P301L transgenic monkey.

Scientific data·2026
Same author

Hgtsynergy: a transfer learning method for predicting anticancer synergistic drug combinations based on a drug-drug interaction heterogeneous graph.

BMC bioinformatics·2026
Same author

Corrigendum to "Selective CP bond cleavage in glyphosate degradation via singlet oxygen-dominated alkali-activated peroxymonosulfate" [J Hazard Mater 496 (2025) 139330].

Journal of hazardous materials·2025
Same author

Selective C-P bond cleavage in glyphosate degradation via singlet oxygen-dominated alkali-activated peroxymonosulfate.

Journal of hazardous materials·2025

相关实验视频

Updated: Jul 28, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K

一种完全基于图形的方法,具有多任务学习,用于预测协同作用的药物组合.

Xiaowen Wang1, Hongming Zhu1, Danyi Chen1

  • 1School of Software Engineering, Tongji University, Shanghai 201804, China.

Bioinformatics (Oxford, England)
|June 1, 2023
PubMed
概括

我们开发了CGMS,这是一种新的深度学习模型,用于预测癌症治疗中的协同药物组合. CGMS提供稳定,顺序独立的预测和改进的概括,优于现有方法.

更多相关视频

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.9K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

相关实验视频

Last Updated: Jul 28, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.9K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

科学领域:

  • 计算生物学是一种计算生物学.
  • 药物发现 药物发现
  • 医学中的人工智能.

背景情况:

  • 药物组合疗法在癌症治疗中比单一疗法具有优势.
  • 药物组合的实验选是具有挑战性的,因为庞大的组合空间.
  • 目前用于药物协同作用预测的深度学习方法存在不稳定性和有限的概括性.

研究的目的:

  • 为了解决现有深度学习模型的药物组合预测的不稳定性和概括性的局限性.
  • 开发一种用于识别新型协同作用药物组合的计算方法.
  • 提高AI在药物发现中的可靠性和适用性.

主要方法:

  • 提出了CGMS,一种将药物组合和细胞系作为异质图形表示的模型.
  • 利用异质图的注意网络来生成整个图的嵌入式来进行交互特征化.
  • 雇员多任务学习,同时对药物协同作用和药物敏感性预测任务进行培训,以提高概括性.

主要成果:

  • CGMS提供了药物协同作用的稳定,顺序独立的预测.
  • 与六种最先进的方法相比,在各种交叉验证场景 (离开药物组合,离开细胞线路,离开药物) 中表现出优越的概括能力.
  • 验证了全图嵌入,注意力机制和多任务学习在提高预测准确性和稳定性的有效性.

结论:

  • CGMS提供了一个强大的和可泛化的深度学习框架,用于预测协同作用的药物组合.
  • 该模型的稳定性和顺序独立性使其成为预先选潜在癌症疗法的可靠工具.
  • CGMS在加速药物发现和优化组合治疗策略方面推进了AI的应用.